MedTrace Logo

IPD Meta-analysis of De-escalation Treatment Strategy After PCI in ACS

NCT04848766 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 9000

Last updated 2021-06-08

No results posted yet for this study

Summary

We will perform a systemic review of previously published data and an updated patient-level meta-analysis of studies, including the most recent publications. PubMed, EMBASE, Cochrane Central Register of Controlled Trials, the United States National Institutes of Health registry of clinical trials, and relevant websites were searched for pertinent published studies.

Conditions

Interventions

DRUG

De-escalation Treatment Strategy of dual antiplatelet therapy

Patients receive de-escalation treatment of dual antiplatelet therapy after percutaneous coronary intervention

Sponsors & Collaborators

  • St. Antonius Hospital

    collaborator OTHER

  • Ludwig-Maximilians - University of Munich

    collaborator OTHER

  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • Kyung Woo Park, MD, PhD · Seoul National University Hospital

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-07
Primary Completion
2021-09-30
Completion
2021-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04848766 on ClinicalTrials.gov